Detalles de la búsqueda
1.
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.
Nature
; 628(8009): 872-877, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570682
2.
Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.
Nature
; 629(8011): E10, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649490
3.
Inhibition of nonsense-mediated decay rescues p53ß/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
J Biol Chem
; 297(5): 101163, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34481841
4.
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stress.
J Cell Sci
; 130(15): 2551-2563, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600325
5.
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
Mod Pathol
; 32(11): 1698-1707, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231128
6.
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
J Thorac Oncol
; 16(4): 601-609, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388476
7.
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.
Cancer Discov
; 9(5): 646-661, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30777870
8.
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.
JAMA Oncol
; 5(1): 67-73, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267032
9.
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.
Cancer Immunol Res
; 6(2): 163-177, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29339375
10.
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
Oncotarget
; 9(18): 14268-14284, 2018 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29581842
11.
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Cell Metab
; 27(5): 977-987.e4, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29628419
12.
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.
Clin Cancer Res
; 23(20): 6239-6253, 2017 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698200
13.
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Cancer Lett
; 392: 71-82, 2017 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28126323
14.
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.
Oncotarget
; 8(49): 86369-86383, 2017 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29156801
15.
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.
Cancer Res
; 77(14): 3870-3884, 2017 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28490518
16.
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
Oncotarget
; 8(17): 28575-28587, 2017 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212573
17.
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.
Oncotarget
; 8(43): 73419-73432, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29088717
18.
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with ß-blockers.
Sci Transl Med
; 9(415)2017 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29118262
19.
Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials.
Am J Clin Nutr
; 103(2): 505-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26791187
20.
Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis.
Cancer Inform
; 15: 81-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27199546